{"id":"W2145879538","doi":"10.1016/j.biomaterials.2013.07.068","title":"Anti-CD30 antibody conjugated liposomal doxorubicin with significantly improved therapeutic efficacy against anaplastic large cell lymphoma","year":2013,"lang":"en","type":"article","venue":"Biomaterials","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"National Center for Research Resources; Canadian Institutes of Health Research; National Institutes of Health; Alberta Cancer Foundation","keywords":"CD30; Anaplastic large-cell lymphoma; Doxorubicin; Medicine; Cancer research; Liposome; Lymphoma; Antibody; Monoclonal antibody; Brentuximab vedotin; Pharmacology; Chemotherapy; Immunology; Chemistry; Internal medicine; Biochemistry","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001385952,0.0003832751,0.00039746,0.0000814418,0.0001302483,0.0001950616,0.0003423848,0.0002509452,0.0001595955],"category_scores_gemma":[0.00001952724,0.0002898203,0.00009969476,0.0001273947,0.0001156775,0.00001767492,0.0001088485,0.00001621923,0.0003267908],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001515656,"about_ca_system_score_gemma":0.0001109365,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009715483,"about_ca_topic_score_gemma":0.00001559397,"domain_scores_codex":[0.9981019,0.0001280068,0.0004195453,0.0006012933,0.0001457032,0.0006035096],"domain_scores_gemma":[0.9989241,0.0000206463,0.0002049873,0.0005210276,0.0001784564,0.0001507254],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003501934,0.0004371529,0.0007350309,0.00003800609,0.000137524,0.00001395202,0.00004663088,0.000003231881,0.9972119,0.000004423097,0.000458732,0.0005632562],"study_design_scores_gemma":[0.003351589,0.00134608,0.01565211,0.00003841356,0.00004838129,0.00001470943,0.00009261785,0.0001031897,0.9771584,0.000003972304,0.001739843,0.0004506738],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977693,0.0003499304,0.0003247448,0.00004703837,0.0004143636,0.0006490496,0.0001251616,0.00006480312,0.0002555875],"genre_scores_gemma":[0.9978861,0.0001367993,0.0001284397,0.0004833864,0.0002733079,0.00005164623,0.0007129366,0.00005975099,0.0002676414],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02005344,"threshold_uncertainty_score":0.9999554,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007358194956652742,"score_gpt":0.2324224090353347,"score_spread":0.2250642140786819,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}